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HIV Clinical Management
Retention in Continuous Care and Sustained
Viral Suppression: Examining the Association
among Individuals Living with HIV
Timothy N. Crawford, PhD, MPH1, and Alice Thornton, MD2
Abstract
Objectives: To examine the relationship between retention in continuous care and sustained viral suppression.Methods: The
authors retrospectively followed 653 persons who were virally suppressed and seeking care at an infectious disease clinic in
Kentucky for an average of 6 years to determine the rates of retention in medical care (2 visits separated by 3 months within a
12-month period) and sustained viral suppression (<400 copies/mL). A generalized linear mixed model was used to determine an
association between retention and suppression over time. Results: Approximately 61% of the study population were retained in
continuous care and 75% had sustained viral suppression for all patient-years. Persons retained in care were 3 times the odds of
sustaining viral suppression over time (P < .001). Conclusion: Retention is essential to achieving and maintaining viral
suppression. Strategies should be set in place that emphasize increasing the rates of retention, which in turn may increase the
rates of suppression.
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Introduction
Achieving and sustaining viral suppression is essential for per-
sons living with HIV. Not only does achieving viral suppres-
sion reduce morbidity and mortality due to HIV, it also reduces
one’s risk of transmitting the virus to others.1 Even so, in the
United States, a large percentage of persons living with HIV
(PLWH) have not achieved viral suppression. It is estimated
that in the United States, approximately 1.2 million people are
living with HIV; and of those, 70% have not achieved viral
suppression.1 There are many factors that may contribute to
individuals not achieving viral suppression, including not being
aware of their infection and not being engaged in care (ie,
retention in care).1,2
Engagement in HIV care is imperative for all PLWH, as this
greatly improves the opportunity to achieve viral suppression.
Specifically, retention in continuous HIV care is an important
piece in the engagement in care continuum, as poor retention
poses an arduous obstacle in increasing the percentage of per-
sons with a suppressed viral load.1-4 However, approximately
one-half or more of PLWH are not retained in continuous care
after being diagnosed and linked to care.1,5,6 Approximately
two-thirds of those that did not have a suppressed viral load
were not engaged in care, whereas 76% of those that were
engaged in care were virally suppressed, suggesting the impor-
tance retention in care plays in the management of HIV
disease.1
When an individual suppresses his or her viral load, it is
important that he or she maintains suppression. Over time, a
large proportion of patients have viral loads that rise above
detectable levels after initial suppression.7-10 Similarly, the
proportion of those retained in continuous care may decrease
over time.11,12 Continuing to understand the association
between retention in continuous care and sustained viral sup-
pression is important. The purpose of this study was to examine
the effects of retention in continuous HIV care and other factors
on sustained viral suppression among Kentuckians living with
HIV.
Methods
Study Design
We retrospectively evaluated patients who were diagnosed
with HIV and sought HIV medical care at an urban, academic
infectious disease clinic between 2003 and 2011. The clinic is a
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multidisciplinary, urban, and academic infectious disease clinic
located in Kentucky. Over half of the patient population lives in
rural areas. Patients who sought care and provided complete
data between 2003 and 2011 were eligible for the study.
Patients who were virally suppressed (viral load <400 copies/
mL) for the first time during the study period were followed for
at least 12 months after the initial viral suppression to examine
the rates of sustained viral suppression. The institutional review
board approved this study.
Study Population and Eligibility
Patients eligible for the study were those who sought care at the
clinic between 2003 and 2011, were diagnosed with HIV, and
were 18 years of age. Patients were included in the study if
they were currently on antiretroviral therapy (ART), had a
suppressed viral load at least once during the study period, and
the initial suppression date allowed for at least 1 year of follow-
up. If a patient had missing diagnosis or clinic visit dates, they
were excluded from the analysis. Each patient included in the
study was followed for 12-month intervals from the time of
their first suppressed viral load until the end of the study period,
death, or movement out of the service region. The follow-up
period extended through December 31, 2011.
Study Measures
Demographic and clinical data for each patient were abstracted
from all medical records. Demographic data collected at base-
line included date of birth, sex, race (white and nonwhite),
marital status (single, married, widowed, and divorced),
employment status (employed, unemployed, and retired/dis-
abled), HIV risk behavior (men who have sex with men
[MSM], heterosexual, injection drug user [IDU], and others),
annual income (US$10 000 and >US$10 000), insurance type
(private, Medicare, Medicaid, and none), and current tobacco
use, alcohol use, and/or illicit drug use. Clinical data collected
at baseline and/or during the follow-up included viral load,
CD4 counts, depression, AIDS diagnosis, and hepatitis C diag-
nosis. After each 12-month follow-up period, viral loads were
collected to determine viral suppression.
The primary independent variable of interest for this study
was retention in continuous care. Retention in continuous care
was defined, using the Institutes of Medicine’s core indicator, as
having 2 clinic visits separated by at least 3 months within a
12-month period.13,14 Whether a patient met the retention cri-
teria or not (yes/no) was observed for each year the patient was
in the study. The percentage of patient-years where an individual
was retained in continuous care was calculated; patients were
considered optimally retained in continuous care if they main-
tained retention 100% of the time while in the study.
Outcome Measure
The outcome measure of interest for this study was sustained
viral suppression. Viral suppression was defined as having a
viral load <400 copies/mL. Viral loads were captured for each
patient at the end of each 1-year period (+90 days). The per-
centage of patient-years where a patient was virally suppressed
was calculated; sustained viral suppression was defined as
maintaining a suppressed viral for all yearly intervals observed
(100%).
Statistical Analysis
To assess trends in viral suppression and retention in care
among the entire group, the proportions of patients with a
suppressed viral load and meeting the retention criteria in each
study year period were calculated. Descriptive statistics were
conducted to describe the cohort, with means, standard devia-
tions (SD), medians, and interquartile ranges (IQR) calculated
for all continuous variables and frequencies and percentages
calculated for all categorical variables. For the bivariate anal-
ysis, w2 tests were performed to determine the differences
between sustained suppression and categorical variables,
whereas independent 2-sample t tests and Wilcoxon rank sum
test (when appropriate) were conducted to determine the dif-
ferences between sustained suppression and continuous
variables.
A generalized linear mixed model (GLMM), using a logit
link function, was used to determine the factors associated
with sustained viral suppression over time; in particular,
retention in care. A GLMM was used for this study due to
the nonnormal data and the repeated measures per individual.
To account for random variation between individuals, we
employed a random intercepts model. The fixed effects were
included in the model as well (eg, age, sex, race, income).
The Gauss-Hermite quadrature method was used for the like-
lihood approximation and the random intercepts model esti-
mated the probability of sustaining a suppressed viral load.
Known confounders and variables with a P values .15 in
the bivariate analysis were initially included in the model and
confounders and variables with a P value <.05 were retained
in the model. In this model, retention in care and depression
were observed as time-varying factors. All data were ana-
lyzed using SAS version 9.4, and P values <.05 were
regarded as statistically significant.
Results
A total of 653 patients, who were on ART and virally sup-
pressed at any time between 2003 and 2011, were included in
the study. The mean age at first suppression was 40.4 years (SD
¼ 9.4). The majority of the patients were male (82.9%), white
(76.3%), single (70.4%), and reported MSM as their HIV risk
behavior (59.7%). Over half (54.4%) of the patients who were
suppressed and sought care during this time period had annual
incomes US$10 000, and almost one-third of the patients
were uninsured. Approximately 61% of the patients were diag-
nosed with AIDS and 42% were diagnosed with depression
during the study period (Table 1).
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The average follow-up time after viral suppression was 6.2
years (SD ¼ 2.5; range ¼ 1-8) and the average number of
outpatient clinic visits attended during this follow-up period
was 9.4 visits (SD ¼ 8.0; range ¼ 1-80). The rate of retention
among this cohort ranged from 94.3% in year 1 to 76.1% in
year 8 (Ptrend  .0001); however, the average overall rate of
retention was 81.9% (SD ¼ 28.9). Overall, approximately 61%
of the patients were optimally retained in continuous care
(Table 1). Optimal retainers were more likely to be older,
MSM, privately insured or on Medicare, and have an annual
income >US$10 000, compared to their counterparts.
Overall, the average percentage of patient-years an individ-
ual was virally suppressed was 87.5% (SD ¼ 26.2). The pro-
portion of patients virally suppressed remained steady over
time, with a slight increase from 2004 (88.5%) to 2011
(92.3%; Ptrend ¼ .04). A total of 487 (74.6%) patients, with
suppressed viral loads, maintained suppression throughout the
course of the study. Individuals with sustained suppression
were more likely to be optimal retainers in care compared to
their counterparts (64.7% versus 49.4%; P ¼ .001). Also, those
with sustained viral suppression were more likely to be white
(78.2% versus 70.5%; P ¼ .04), employed (48.1% versus
37.8%; P ¼ .05), and privately insured (32.4% versus 18.7%;
P¼ .004). Sustained suppression was less likely to be observed
among the uninsured (29.1% versus 40.4%; P ¼ .004), those
diagnosed with depression (38.2% versus 53.0%; P ¼ .001),
those diagnosed with AIDS (57.3% versus 71.1%; P ¼ .002),
and those diagnosed with hepatitis C (12.3% versus 18.7%; P¼
.04; Table 1).
A GLMM was performed to determine which factors were
associated with sustained viral suppression over time, in par-
ticular retention in continuous care. Table 2 presents the asso-
ciations between each factor and sustained suppression. The
results suggest that individuals who were optimally retained
in continuous care had greater odds of sustaining suppressed
viral loads. While controlling for all other variables in the
Table 1. Association of Demographic Characteristics and Sustained Viral Suppression among Patients Virally Suppressed and Seeking HIV
Medical Care in Kentucky, 2003-2011.a
Characteristics Total, n (%)
Sustained Viral Suppression
P ValueYes, n (%) No, n (%)
Total 653 (100) 487 (74.6) 166 (25.4) 
Age at baseline, mean (SD), years 40.4 (9.4) 40.8 (9.6) 39.2 (37.8) .06
Sex—male 541 (82.9) 409 (84.0) 132 (79.5) .19
Race—white 498 (76.3) 381 (78.2) 117 (70.5) .04
Marital status .86
Single 445 (70.4) 330 (70.1) 115 (71.4)
Married 97 (15.4) 75 (15.9) 22 (13.7)
Widowed 22 (3.5) 17 (3.6) 5 (3.1)
Divorced 68 (10.8) 49 (10.4) 19 (11.8)
Employment status .05
Employed 260 (45.4) 203 (48.1) 57 (37.8)
Unemployed 196 (34.2) 133 (31.5) 63 (41.7)
Retired/disabled 117 (20.4) 86 (20.4) 31 (20.5)
HIV risk behavior .33
MSM 390 (59.7) 296 (60.8) 94 (56.6)
Heterosexual 176 (27.0) 133 (27.3) 43 (25.9)
IDU 55 (8.4) 36 (7.4) 19 (11.5)
Other 32 (4.9) 22 (4.5) 10 (6.0)
Annual income—US$10 000 309 (54.4) 216 (52.4) 93 (59.6) .12
Insurance status .004
Private 188 (28.9) 157 (32.4) 31 (18.7)
Medicare 140 (21.5) 103 (21.3) 37 (22.3)
Medicaid 114 (17.5) 83 (17.2) 31 (18.7)
None 208 (32.0) 141 (29.1) 67 (40.4)
Tobacco use—yes 337 (51.6) 241 (49.5) 96 (57.8) .06
Alcohol use—yes 327 (50.1) 236 (48.5) 91 (54.8) .16
Illicit drug use—yes 146 (22.4) 103 (21.2) 43 (25.9) .20
Optimal retention—yes 397 (60.8) 315 (64.7) 82 (49.4) .001
Depression during study—yes 274 (42.0) 186 (38.2) 88 (53.0) .001
AIDS diagnosis—yes 397 (60.8) 279 (57.3) 118 (71.1) .002
Hepatitis C diagnosis—yes 91 (13.9) 60 (12.3) 31 (18.7) .04
Baseline CD4 count—<200 145 (23.7) 107 (23.3) 38 (24.7) .73
Baseline viral load—median log copies (IQR) 3.9 (3.9-4.7) 3.9 (3.9-4.5) 3.9 (3.9-5.0) .002
Abbreviations: HIV, human immunodeficiency virus; IDU, injection drug user; IQR, interquartile range; MSM, men who have sex with men; SD, standard deviation.
aN ¼ 653.
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model, an individual who retained in continuous care through-
out the course of the study were almost 3 times the odds of
sustaining a suppressed viral load compared to those not
retained in continuous care over time (odds ratio [OR]: 2.97;
95% confidence interval [CI]: 1.65-5.32). Also, those at greater
odds of sustaining a suppressed viral load were found among
older patients (OR: 1.05; 95% CI: 1.01-1.08) and those pri-
vately insured compared to those not insured (OR: 2.32; 95%
CI: 1.07-5.02). Nonwhites, which consisted of blacks and His-
panics, were at much lower odds of sustained suppression over
time compared to whites (OR: 0.51; 95% CI: 0.26-0.98). In
addition, those with depression, AIDS, or hepatitis C were at
lower odds of sustaining suppressed viral loads compared to
their counterparts (Table 2).
Discussion
In this study, we examined the factors that were associated with
sustained viral suppression, in particular retention in continuous
care. We retrospectively followed 653 patients who were virally
suppressed and seeking medical care for an average of 6 years to
determine the rates of retention and sustained suppression.
Among the 653 patients included in the study, optimal retainers
were at increased odds of sustaining viral suppression over time
compared to those not retained in care. The results of this study
suggest that seeking continuous care even after viral suppression
is vital, and this can help maintain viral suppression over time. In
this study, we showed that approximately 75% of the cohort had
sustained viral suppression for all patient-years observed. There
were also significant increases in the rates of suppression as the
rates increased from 88% in year 1 to 95% in year 8. Our study
results corroborate other studies that have shown significant
increases in the rates of suppression over time.15-18 Yehia et al
showed significant increases in the rates of sustained suppression
among 483 patients who received care between 2001 and 2010;
the rates of suppression increased from 45% in 2001 to 72% in
2010.15 Westergaard et al conducted a study among HIV-
infected IDUs and observed that the rates of suppression
increased from 15.7% in 1998 to 60% in 2011.16
Our rates of suppression were slightly higher compared to
other studies that observed sustained suppression.1,3,15,16,19,20
This could be due to our definition of viral suppression (ie,
<400 copies/mL). To maintain consistency between those who
initiated care at earlier time period and those who initiated care
at later time periods, we stuck with <400 copies/mL as the
cutoff. Other studies have used <50, <200, or <500 copies/
mL as their cutoff for suppression. Because of this inconsis-
tency, it is difficult to compare studies. Although not shown, a
sensitivity analysis was conducted comparing the different
measurement levels, and the results remained the same.
Improved rates of sustained suppression were found among
those who sought continuous care (ie, retention) compared to
those who did not. In our study, approximately 61% of the
cohort met the retention criteria in all patient-years. This reten-
tion rate falls within the range of other studies as researchers
have shown retention rates ranging between 30% and
90%.1,6,13,17,20-23 Retention in continuous care after initial viral
suppression increased the odds of sustained viral suppression.
This shows the importance of retaining in care even after
achieving viral suppression. It is suggested that individuals
living with HIV who have achieved viral suppression should
attend a clinic visit at least once every 6 months.24 Those
individuals that do not seek continuous care risk the chance
of their viral loads rising above detectable levels, and from a
public health standpoint, this is extremely important as this
could increase their risk of transmitting the virus onto others.25
The results of the current study are similar to other studies that
have shown poor retention to be associated with low rates of
viral suppression.4,12,17,26 In a similar study, Crawford showed
that suboptimal retainers, compared to optimal retainers, had
twice the odds of experiencing a viral rebound (viral load >400
copies/mL) after initial viral suppression.4 Retaining PLWH in
continuous care is essential in order to increase the percentage
of persons who achieve viral suppression. Researchers and
clinicians should direct their focus and interventions to improv-
ing retention in care, such as service delivery interventions.27,28
Poor rates of sustained viral suppression were found among
younger patients, nonwhites, those uninsured, and those with
an HIV diagnosis. This is similar to other studies that have
observed factors related to viral suppression.15-18,29 Similar
to other studies, nonwhites have a harder time suppressing their
viral loads.26,29 This could be due to multiple reasons, in par-
ticular retention in care. Although not shown, nonwhites were
less likely to be optimally retained in care compared to whites.
This could explain poor rates of sustained suppression among
this group. Blacks and Hispanics were grouped into nonwhites
due to the small sample sizes as the HIV population in
Kentucky is predominately white and non-Hispanic.
Table 2. Generalized Linear Mixed Model to Determine Sustained
Viral Suppression over Time among Patients Virally Suppressed and
Seeking Care in Kentucky, 2003-2011.a,b
Characteristics
Sustained Viral
Suppression
P ValueaOR 95% CI
Retention (yes versus no)c 2.97 1.65-5.32 <.001
Age 1.05 1.01-1.08 .01
Race (nonwhite versus white) 0.51 0.26-0.98 .04
Insurance type
Private versus none 2.32 1.07-5.02 .03
Medicare versus none 1.33 0.60-2.97 .48
Medicaid versus none 1.24 0.54-2.84 .61
Depression (yes versus no)c 0.47 0.28-0.77 .003
AIDS diagnosis (yes versus no) 0.32 0.16-0.62 .001
Hepatitis C diagnosis (yes versus no) 0.38 0.17-0.81 .01
Baseline CD4 count (<200 versus 200) 1.22 0.59-2.55 .59
Baseline viral load (per 1 log copy) 0.63 0.41-0.96 .03
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; GLMM,
generalized linear mixed model.
aN ¼ 613.
bGLMM controlled for year in study.
cTime-varying factors.
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An interesting result was that those who were diagnosed
with depression had lower odds of sustained suppression com-
pared to those who were not depressed. A large proportion
(42%) of our cohort were diagnosed with depression through-
out the study period. Depression among PLWH is not uncom-
mon, but only a small number of researchers have observed the
effect depression has on HIV outcomes.30-32 It is important to
make sure these individuals are getting the care they need to
address their depression and this in turn may have a positive
effect on their viral suppression.
There were a few limitations to the current study. The study
was an observational, retrospective cohort study. Due to the
retrospective nature of this study, we can only discuss associ-
ation and not causation. Also, the study was subjected to
uncontrolled confounders for which we did not have any infor-
mation (eg, education). Another limitation of this study is that
we did not obtain data on medication adherence. This informa-
tion was not captured in the medical records and therefore we
were not able to look at the association between sustained
suppression and medication adherence. Also, our results may
not be generalizable to all PLWH receiving ART. The strength
of this study is that we looked at the longitudinal nature of
retention in continuous care and viral suppression among indi-
viduals who achieved a suppressed viral load.
In conclusion, the results of this study carry significant
implications for clinical outcomes of PLWH as well as future
public health prevention efforts. Retention in HIV medical care
plays a central role in sustaining viral suppression. The results
of this study showed that individuals who are retained in care
over time have greater odds of sustaining viral suppression
compared to their counterparts. Interventions should be set in
place that put an emphasis on increasing rates of retention in
care which in turn increases the rates of viral suppression.
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